-Provides clinical management and oversight of the Institute for Behavioral Resources opioid treatment program, providing methadone maintenance therapy, buprenorphine maintenance therapy, care coordination, counseling services, and group therapy to patients with substance use disorders. - Collaborates with graduate medical training programs to facilitate addiction medicine training and curricular experiences for residents and fellows- Collaborates with academic researchers to ensure successful implementation of research protocols for novel clinical applications to advance the treatment of substance use disorder conditions - Partners with community providers to ensure continuity of care for patients currently receiving substance use disorder treatment

Provides consultation services for Maryland community-based physicians seeking help with their patients diagnosed with various substance use disorders and facilitating access to evidence-based recommendations for the management of a wide range of substance use disorder and harm reduction issues.

- Provides comprehensive addiction medicine care to patients with a variety of substance use disorders in the inpatient and ambulatory settings.- Serves as Chair of the Opioid Task Force responsible for developing and managing population health metrics addressing opioid prescribing and education, academic detailing, regulatory compliance and risk mitigation for the Midtown hospital system with the goal of implementing strategies to reduce the number of chronic opioid prescriptions above 90 morphine milliequivalents- Serves as Medical Director of Employee Health providing medical review officer services for new hospital employee hires, ensures vaccination integrity and availability for all hospital staff, and managing employee safety and all hazardous exposure situations occurring in the Midtown hospital system.

Key Achievements:- Provides Medical Director services to opioid treatment programs A Helping Hand and Genesis Treatment Services - Refined harm reduction education materials for Maryland Department of Health Regrounding Our Response program to improve community health worker understanding of stigma, social determinants of health, and medication assisted treatment strategies associated with opioid addiction.- Provided testimony to US House of Representative Judiciary Subcommittee on Crime Terrorism and Homeland Security on cannabis and racial justice, leading to the introduction of the Marijuana Opportunity Reinvestment and Expungement Act. - Provided oral and written testimony to regulatory agencies, legislative bodies which facilitated the development of drug policy legislation and regulation in New Jersey, New York, Ohio, Pennsylvania and Tennessee. Guest lectured at numerous academic institutions including Princeton, Yale, Duke, Cornell, University of Cincinnati, and University of Maryland.- Co-founded and developed the Tribe Companies limited liability company, a multi-state, vertically integrated cannabis company directing the development and construction of 6.2 acres of property for commercial cannabis operations containing 162,000 square feet of real estate, including negotiating contracts with multiple vendors, procuring equipment, and maintaining federal, state and local governmental compliance across a $15M project budget.- Developed corporate policies and procedures for a team of 18 employees, covering topics including human resources, technology utilization, performance management, daily standard operating procedures, and regulatory compliance with local, state and federal agencies.

- Prepared plans for project development, implementation, evaluation and coordination of harm reduction services with emphasis on connection to medical care for syringe service programs, overdose response programs, and drug checking programs statewide.- Developed and delivered technical assistance to stakeholders for the implementation of innovative harm reduction projects and activities.- Interpreted policies related to public health and disseminated information, procedures, and guidelines established by state and federal agencies.- Provided medical coverage for statewide overdose response program ensuring naloxone access to over 250 community based organizations.

Managed the company’s the largest two opioid treatment programs in the country caring for over 1200 patients providing access to medications for opioid use disorder to patients with polysubstance use disorder and facilitating referrals to general primary care, infectious disease, mental health, wound healing, dental and social services.

Conducts complete history and physical exams both in person and via telemedicine for eligible Medicare Advantage beneficiaries to ensure all chronic diseases, medications, and lab results are appropriate.

Provides DOT fitness for duty physical exams and medical review officer services for commercial truck drivers and other CDL licenses holders reviewing medications, lab results, and chronic diseases, and other occupational health concerns to ensure compliance with Federal Motor Carrier Safety Administration standards

Key Achievements:- Partnered with the Johns Hopkins Lancet Commission on Drugs to facilitate the development of a policy brief regarding international drug policy reform and public health in preparation for the United Nations General Assembly Special Session on Drugs. - Established surveillance tools and reporting methods for the county health departments as a contributor to the Maryland Governor Larry Hogan’s opioid response taskforce.- Analyzed, provided public testimony, and engaged in direct lobbying on drug policy legislation and regulation within the District of Columbia, Maryland, Ohio, Vermont, and Missouri.- Pioneered the development of clinical programs within the Johns Hopkins Community Physicians Internal Medicine practice focused on enhancing patient care for long-term chronic opioid therapy.

Key Achievements:- Orchestrated the campaign to legalize marijuana in the Nation’s Capital, gathering 57,000 signatures to place Initiative 71 on the November ballot and winning the election with 71% of the vote- Developed first in the nation legislation which creates a regulatory structure for legal marijuana grounded in racial and social justice - Lobbied local and federal officials to advance marijuana policy reform in the Nation’s capital- Organized community organizations, civil rights advocacy groups and labor groups around the cause for drug policy reform - Published articles on drug policy issues in major media outlets including CNN, New York Times, Washington Post, and Huffington Post

- Contextualized the impact of board decisions on the graduate school experience at the 10 graduate schools of Duke University with the goal of improving board governance structure. - Reviewed facility design and business operations for the renovation and redesign of the University student union.- Appraised the governance structure, business operations and financial viability, and educational enterprise of Duke School of Medicine in context of changing government regulations.

- Coordinated the preoperative and postoperative care of 750 surgical patients - Conducted analysis of work hour violations resulting in a change in documentation policy within the department - Performed 100 general surgery procedures within the various subspecialties of the field - Taught 25 3rd and 4th year medical students about the care of surgical patients